Hoybye, Charlotte; Weber, Matthias M.; Pournara, Effie et al.
Is GH dosing optimal in female patients with adult-onset GH deficiency? An analysis from the NordiNet (R) International Outcome StudyCLINICAL ENDOCRINOLOGY. Bd. 86. H. 6. 2017 S. 798-805
Neumann, Helmut; Neumann, Helmut; Thieringer, Florian et al.
Leaving Colorectal Polyps in Place Can Be Achieved With High Accuracy Using Blue Light Imaging (BLI)GASTROINTESTINAL ENDOSCOPY. Bd. 85. H. 5. 2017 S. AB385-AB385
Deterding, K.; Mauss, S.; Pathil, A. et al.
Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters - Results from the German Hepatitis C-Registry (DHC-R)JOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S55-S55
Vollmar, Johanna; Lautem, Anja; Closs, Ellen et al.
Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesisONCOTARGET. Bd. 8. H. 70. 2017 S. 115667-115680
Panova-Noeva, Marina; Arnold, Natalie; Hermanns, M. Iris et al.
Mean Platelet Volume and Arterial Stiffness - Clinical Relationship and Common Genetic VariabilitySCIENTIFIC REPORTS. Bd. 7. 2017
Reichenbach, Frank; Wiedenmann, Cornelius; Schalk, Enrico et al.
Mitochondrial BAX Determines the Predisposition to Apoptosis in Human AMLCLINICAL CANCER RESEARCH. Bd. 23. H. 16. 2017 S. 4805-4816
zur Hausen, G.; Waidmann, O.; Woerns, M. -A et al.
Nab-paclitaxel/Gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values - data from the German QoliXane pancreatic cancer registryONCOLOGY RESEARCH AND TREATMENT. Bd. 40. 2017 S. 259-259
Sebastiani, M.; Codullo, V.; Manfredi, A. et al.
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROMEANNALS OF THE RHEUMATIC DISEASES. Bd. 76. 2017 S. 1281-1282
Labenz, Christian; Schattenberg, Joern M.
NASH - Is the Time come for a Drug Therapy? Prime Time for Medical Therapy in NASH?ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 55. H. 1. 2017 S. 83-84
Gottwald-Hostalek, Ulrike; Uhl, Wolfgang; Wolna, Peter et al.
New levothyroxine formulation meeting 95-105% specification over the whole shelf-life: results from two pharmacokinetic trialsCURRENT MEDICAL RESEARCH AND OPINION. Bd. 33. H. 2. 2017 S. 169-174